CHI3L2 Polyclonal Antibody

CAT:
498-bs-12358R
Size:
100 µL
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
CHI3L2 Polyclonal Antibody - image 1

CHI3L2 Polyclonal Antibody

  • Background:

    YKL-39 is a 390 amino acid cartilage protein that belongs to the chitinase family of chitin-fragmenting hydrolases. Highly expressed in chondrocytes (cartilage cells) and synoviocytes (fibroblastic cells that line joint cavities), YKL-39 binds glycan structures with high affinity. Although related to bacterial chitinases, YKL-39 lacks the characteristic glutamate active site and, thus, does not have enzymatic chitinase activity. Patients affected with rheumatoid arthritis (RA) have autoimmunity against YKL-39, suggesting that YKL-39 is involved in osteoarthritic and/or rheumatoid joint disease. Additionally, YKL-39 is upregulated in early degenerative cartilage diseases (such as RA) and may be a marker of chondrocyte activation in these autoimmune conditions.
  • Synonyms:

    CH3L2_HUMAN; CHI3L2; Chitinase 3 like 2; Chitinase-3-like protein 2; Chondrocyte protein 39; OTTHUMP00000014028; YKL 39; YKL-39; YKL39.
  • Gene ID:

    7690
  • Cellular Locus:

    Secreted
  • Host:

    Rabbit
  • Immunogen:

    121-220/390
  • Target:

    CHI3L2
  • Clonality:

    Polyclonal
  • Isotype:

    IgG
  • Conjugation:

    Unconjugated
  • Source:

    KLH conjugated synthetic peptide derived from human YKL39/CHI3L2
  • Applications:

    WB, ELISA, IHC-P, IHC-F, IF (IHC-P), IF (IHC-F), IF (ICC)
  • Purification:

    Purified by Protein A.
  • Concentration:

    1µg/µl
  • Dilution:

    WB (1:300-5000), ELISA (1:500-1000), IHC-P (1:200-400), IHC-F (1:100-500), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
  • Buffer:

    0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
  • Modification:

    Unmodified
  • Storage Conditions:

    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
  • Gene ID URL:

    7690
  • Predicted Cross Reactivity:

    Human